Skip to content

PTHS PTHS Debt issuance costs and discount amortization

Debt issuance costs and discount amortization at other companies

Journey Medical Corporation logo
Journey Medical CorporationDERM
$96K-5.0%

Other financials

Income statement

See full
Revenue$10.9M
Gross profit$9.2M
Operating income-$13.1M-614%
Net income-$10.2M-420%
EPS (diluted)-$3.09+3.7%

Balance sheet

See full
Cash & equivalents$32.0M+24,250%
Total debt$29.6M
Total equity$35.1M+937%
Total assets$145.4M+15,855%

Cash flow

See full
Operating cash flow-$13.1M-1,977%
CapEx$194.0K
Free cash flow-$13.3M-2,008%

Valuation

See full
Market cap$98.22M+92.4%
Enterprise value$95.89M
P/S3.6×

Profitability

See full
Gross margin79.6%
Operating margin-157.7%
Net margin-186.2%
FCF margin-60.8%

Returns & leverage

See full
Return on equity-333.8%
Debt / equity0.8×
Current ratio2.8×+2.6×

Where this comes from

Reported directly by PTHS in its filing.

Tagged under the XBRL concept us-gaap:AmortizationOfDebtDiscountPremium.

The official record: PTHS’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →

Ask your AI about PTHS's debt issuance costs and discount amortization.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is PTHS's debt issuance costs and discount amortization?
PTHS (PTHS) reported debt issuance costs and discount amortization of $195K in Q1 2026.
How has PTHS's debt issuance costs and discount amortization changed year-over-year?
PTHS's debt issuance costs and discount amortization increased by 107.4% year-over-year, from $94K to $195K.
What is the long-term trend for PTHS's debt issuance costs and discount amortization?
Over 2 years (2023 to 2025), PTHS's debt issuance costs and discount amortization has grown at a 17.3% compound annual growth rate (CAGR), from $188.12K to $259K.
What does debt issuance costs and discount amortization mean?
Captures the non-cash allocation of debt issuance costs and original issue discounts over the life of a debt instrument. This expense effectively increases the reported interest expense to reflect the true cost of borrowing beyond the stated coupon rate. It is essential for understanding the total effective interest burden on the company's capital structure.